Year 2019 / Volume 26 / Number 2

Abstract PDF

Caso Clínico

Does pregabalin is a safe drug? Heart failure associated with pregabalin

Rev. Soc. Esp. Dolor. 2019; 26(2): 124-125 / DOI: 10.20986/resed.2017.3537/2016

Belinda Montalbán Moreno, Vanessa Jiménez Jiménez, María Teresa González López, Carmen María Mateo Cerdán, Rocio Jiménez Tortosa, María Girón Lacasa, Ana Belén Cuartero del Pozo, Martín Zacarías Arcas Molina


ABSTRACT

In all clinical studies that pregabalin has been used for the treatment of neuropathic pain it is concluded that it is a drug insurance. However, during the post-marketing experience they have been reported cases of congestive heart failure.



RESUMEN

En los estudios clínicos en los que se ha utilizado pregabalina para el dolor neuropático se concluye que es un fármaco seguro. Sin embargo durante la experiencia postcomercialización se han notificado casos de insuficiencia cardiaca congestiva.


New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

Related articles

Analgesic efficacy of tapentadol, alone or in combination, in patients with neuropathic pain (DN): experience in 80 cases

Rev. Soc. Esp. Dolor. 2024; 31(1): 12-15 / DOI: 10.20986/resed.2024.4083/2023

Efficacy of pregabalin, gabapentin and duloxetine in neuropathic pain verified by the p-curve analysis

Rev. Soc. Esp. Dolor. 2020; 27(1): 16-23 / DOI: 10.20986/resed.2020.3727/2019

Evidence-based recommendations for the management of neuropathic pain (review of the literature)

Rev. Soc. Esp. Dolor. 2018; 25(6): 349-358 / DOI: 10.20986/resed.2018.3673/2018

Farmacologic adyuvants with saving effect of opioids in the perioperative period

Rev. Soc. Esp. Dolor. 2018; 25(5): 278-290 / DOI: 10.20986/resed.2018.3663/2018

Citation tools

Montalbán Moreno B, Jiménez Jiménez V, González López M, Mateo Cerdán C, Jiménez Tortosa R, Girón Lacasa M, et all. Does pregabalin is a safe drug? Heart failure associated with pregabalin. Rev Soc Esp Dolor 2019; 26(2): 124-125 / DOI: 1020986/resed20173537/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 137 visits.
This article has been downloaded 1 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 01/11/2016

Accepted: 02/11/2016

Online First: 17/01/2017

Published: 15/04/2019

Article Online First time: 77 days

Article editing time: 895 days


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
Send by e-mail
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexed in:
Legal Notice